Baxter International

Baxter International

Verified
Every day, Baxter touches the lives of millions of patients and providers worldwide who rely on our essential hospital and renal products and services

Launch date
Employees
Market cap
$27.9b
Net debt
($15.3b)
Firm valuation
$43.2b (Public information from Sep 2022)
Deerfield Illinois (HQ)
Deals in current and previous year:

Financials

Edit
Revenues, earnings & profits over time
EUR2016201720182019202020212022E
Revenues-9.6b10.1b10.3b10.6b11.6b14.5b
% growth--5 %2 %3 %10 %24 %
EBITDA20m2.1b2.3b2.5b2.5b2.7b3.5b
% EBITDA margin-22 %23 %24 %23 %23 %24 %
Profit<1m652m1.5b910m1.0b1.2b1.6b
% profit margin-7 %15 %9 %9 %10 %11 %
EV / revenue-3.4x3.3x3.9x3.7x4.5x2.7x
EV / EBITDA-15.4x14.4x16.4x16.1x19.2x11.3x
R&D budget538m514m549m490m---
R&D % of revenue-5 %5 %5 %---

Source: Company fillings or news article

  • Edit
DateInvestorsAmountRound
-N/A-
Not yet verified
$635mAcquisition
Total Funding-

Recent News about Baxter International

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.
Investments analysisEdit

Investments by Baxter International

Edit
Cheetah Medical
ACQUISITION by Baxter International Sep 2019
FLOWSENSE
ACQUISITION by Baxter International Sep 2013
Prism Pharmaceuticals
ACQUISITION by Baxter International Apr 2011
Naurex
ACQUISITION by Allergan Jul 2015
AesRx
ACQUISITION by Baxter International Jul 2014
Gambro
ACQUISITION by Baxter International Sep 2013
View 10 more